Search by Drug Name, NDC or Jcode

    Internal Navigation

    HCPCS Details

    HCPC J2675
    Short Description Inj progesterone per 50 mg
    Long Description Injection, progesterone, per 50 mg
    Pricing indicator 51
    Coverage code D
    ASC payment group code
    BETOS2 code O1E
    Action code N
    Type of service 1
    Effective date 2002-07-01
    Date Added 1986-01-01

    HCPCS/NDC Cross-Walk

    NDC HCPC Description Drug Name Labeler Name HCPCS Dosage PKG Size PKG QTY Bill Units Bill Units PKG
    00143972501 J2675 Inj progesterone per 50 mg Progesterone HIKMA PHARMACEUTICALS USA INC. 50 MG 10 1 10 10
    00591312879 J2675 Inj progesterone per 50 mg Progesterone ACTAVIS PHARMA, INC. 50 MG 10 1 10 10
    55150030610 J2675 Inj progesterone per 50 mg Progesterone AUROMEDICS PHARMA LLC 50 MG 10 1 10 10
    63323026110 J2675 Inj progesterone per 50 mg Progesterone FRESENIUS KABI 50 MG 10 1 10 10
    70700028622 J2675 Inj progesterone per 50 mg Progesterone XIROMED 50 MG 10 1 10 10
    The ASP crosswalks are maintained by the Division of Data Analysis and Market Based Pricing to support ASP-based Medicare Part B payments only. The crosswalks are intended to help the public (including entities that submit manufacturer ASP data and providers who bill for drugs) understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes. The crosswalks are not intended to be a comprehensive list of all drugs/NDCs available in the United States. The NDC to HCPCS Crosswalk also includes information on the NDC package size and the number of billable units (as defined by the HCPCS code descriptor). Comments on the file may be sent to [email protected].

    HCPCS Billing Calculator

    Dosage given to patient (per dose)
    HCPCS Dosage 50 MG
    HCPCS/CPT Billing Units 0.02
    Total doses ordered
    Billing Units 0.02

    Drug Details

    • Progesterone is used as a part of hormone replacement therapy in women who have passed menopause (the change of life) and have not had a hysterectomy (surgery to remove the uterus). Hormone replacement therapy usually includes estrogen, which is used to treat symptoms of menopause and reduce the risk of developing certain diseases. However, estrogen can also cause abnormal thickening of the lining of the uterus and increase the risk of developing uterine cancer. Progesterone helps to prevent this thickening and decreases the risk of developing uterine cancer. Progesterone is also used to bring on menstruation (period) in women of childbearing age who have had normal periods and then stopped menstruating. Progesterone is in a class of medications called progestins (female hormones). It works as part of hormone replacement therapy by decreasing the amount of estrogen in the uterus. It works to bring on menstruation by replacing the natural progesterone that some women are missing.